List of Tables
    Table 1. Gene Therapies for Cancer Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Gene Therapies for Cancer Treatment Market Trends
    Table 3. Gene Therapies for Cancer Treatment Market Drivers
    Table 4. Gene Therapies for Cancer Treatment Market Challenges
    Table 5. Gene Therapies for Cancer Treatment Market Restraints
    Table 6. Global Gene Therapies for Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gene Therapies for Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gene Therapies for Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gene Therapies for Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gene Therapies for Cancer Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gene Therapies for Cancer Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Gene Therapies for Cancer Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Gene Therapies for Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Gene Therapies for Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2021)
    Table 15. Top Players of Gene Therapies for Cancer Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Gene Therapies for Cancer Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Gene Therapies for Cancer Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Gene Therapies for Cancer Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Gene Therapies for Cancer Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Gene Therapies for Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Gene Therapies for Cancer Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Gene Therapies for Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Gene Therapies for Cancer Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Gene Therapies for Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Gene Therapies for Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Gene Therapies for Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Takara Bio Company Details
    Table 31. Takara Bio Business Overview
    Table 32. Takara Bio Gene Therapies for Cancer Treatment Product
    Table 33. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 34. Takara Bio Recent Development
    Table 35. Tocagen Company Details
    Table 36. Tocagen Business Overview
    Table 37. Tocagen Gene Therapies for Cancer Treatment Product
    Table 38. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 39. Tocagen Recent Development
    Table 40. VBL Therapeutics Company Details
    Table 41. VBL Therapeutics Business Overview
    Table 42. VBL Therapeutics Gene Therapies for Cancer Treatment Product
    Table 43. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 44. VBL Therapeutics Recent Development
    Table 45. Cold Genesys Company Details
    Table 46. Cold Genesys Business Overview
    Table 47. Cold Genesys Gene Therapies for Cancer Treatment Product
    Table 48. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 49. Cold Genesys Recent Development
    Table 50. Genprex Company Details
    Table 51. Genprex Business Overview
    Table 52. Genprex Gene Therapies for Cancer Treatment Product
    Table 53. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 54. Genprex Recent Development
    Table 55. Momotaro-Gene Company Details
    Table 56. Momotaro-Gene Business Overview
    Table 57. Momotaro-Gene Gene Therapies for Cancer Treatment Product
    Table 58. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 59. Momotaro-Gene Recent Development
    Table 60. MultiVir Company Details
    Table 61. MultiVir Business Overview
    Table 62. MultiVir Gene Therapies for Cancer Treatment Product
    Table 63. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 64. MultiVir Recent Development
    Table 65. SynerGene Therapeutics Company Details
    Table 66. SynerGene Therapeutics Business Overview
    Table 67. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product
    Table 68. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 69. SynerGene Therapeutics Recent Development
    Table 70. Ziopharm Oncology Company Details
    Table 71. Ziopharm Oncology Business Overview
    Table 72. Ziopharm Oncology Gene Therapies for Cancer Treatment Product
    Table 73. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 74. Ziopharm Oncology Recent Development
    Table 75. Anchiano Therapeutics Company Details
    Table 76. Anchiano Therapeutics Business Overview
    Table 77. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product
    Table 78. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 79. Anchiano Therapeutics Recent Development
    Table 80. Celgene Company Details
    Table 81. Celgene Business Overview
    Table 82. Celgene Gene Therapies for Cancer Treatment Product
    Table 83. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 84. Celgene Recent Development
    Table 85. Celsion Company Details
    Table 86. Celsion Business Overview
    Table 87. Celsion Gene Therapies for Cancer Treatment Product
    Table 88. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 89. Celsion Recent Development
    Table 90. Bluebird Bio Company Details
    Table 91. Bluebird Bio Business Overview
    Table 92. Bluebird Bio Gene Therapies for Cancer Treatment Product
    Table 93. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 94. Bluebird Bio Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gene Therapies for Cancer Treatment Product Picture
    Figure 2. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gene Therapies for Cancer Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Gene Therapies for Cancer Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Gene Therapies for Cancer Treatment Market Share in Global 2017-2028
    Figure 7. Gene Therapies for Cancer Treatment Report Years Considered
    Figure 8. Product Picture of Somatic Cell Gene Therapy (SCGT)
    Figure 9. Product Picture of Germline Gene Therapy (GGT)
    Figure 10. Global Gene Therapies for Cancer Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Gene Therapies for Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Type (2017-2028)
    Figure 13. United States Gene Therapies for Cancer Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Gene Therapies for Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Gene Therapies for Cancer Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Cancer Research Centers
    Figure 17. Product Picture of Diagnostic Laboratories
    Figure 18. Product Picture of Cancer Hospitals
    Figure 19. Product Picture of Others
    Figure 20. Global Gene Therapies for Cancer Treatment Market Share by Application in 2022 & 2028
    Figure 21. Global Gene Therapies for Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Gene Therapies for Cancer Treatment Market Share by Application (2017-2028)
    Figure 23. United States Gene Therapies for Cancer Treatment Market Share by Application in 2022 & 2028
    Figure 24. United States Gene Therapies for Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Gene Therapies for Cancer Treatment Market Share by Application (2017-2028)
    Figure 26. North America Gene Therapies for Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Gene Therapies for Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 55. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 56. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 57. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 58. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 59. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 60. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 61. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 62. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 63. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 64. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 65. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 66. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed